Shiner Yotam, Lubianiker Barak, Doweck Ilana
Department of Otolaryngology Head and Neck Surgery, Carmel Medical Center, Haifa, Israel.
Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Harefuah. 2020 Feb;159(1):77-82.
To evaluate predictive factors for local control, larynx preservation and overall survival in patients with early laryngeal cancer, who were treated with endoscopic transoral CO2 laser microsurgery.
Transoral laser microsurgery (TLM) is the treatment of choice for early laryngeal cancer. The current study aimed to assess the outcomes and validity of carbon dioxide (CO2) laser microsurgery in patients with early larynx cancer and to determine predictors for outcomes.
A retrospective study included all patients who were treated with laser microsurgery, in the Department of Otolaryngology, Head and Neck Surgery, Carmel Medical Center, Haifa, between the years 2009-2016. We evaluated outcomes according to local control, margin status, larynx preservation, and overall survival. Cordectomy types I-V were classified by the European Laryngological Society (ELS).
Laser microsurgery was performed in 74 patients with early laryngeal cancer, mean age 68.2±10.4 years, M: F 65:9, mean follow-up 58±28 months. Seventy-three percent (73%) were smokers. Primary tumor location was glottic in 68 patients (92%), supraglottic (5 patients - 7%), and subglottic (1 patient - 1%). Tumor stage was as follows: Tis: 18 patients (24%), T1a: 35 patients (47%), T1b:10 patients (14%) and T2: 11 patients (15%). In 72 patients (97%), margins were taken from the patient side, 64% (46 patients) had negative margins, whereas 26 patients (36%) had positive margins. Patients with positive margins had either further laser surgery (19%), or radiotherapy (14%). Two patients were not treated for positive margins, both had recurrent disease in a mean follow-up of 26 months, and both had total laryngectomy. Five years local control rate (LCR) stratified by stage was as follows: Tis-81.5%, T1a- 88%, T1b-100% and T2 - 58% (NS). Overall 5-year local control rate (LCR) was 83%, with no significant difference between patients with positive or negative margins. Overall 5-year survival was 87% and organ preservation rate was 93.
Laser microsurgery provides an excellent rate of disease free/overall survival for early laryngeal cancer and has a valuable role in organ preservation. No significant differences were found in LRC and overall survival between patients with positive margins compared to patients with negative margins, most probably due to immediate further intervention in patients with positive margins.
评估接受内镜经口二氧化碳激光显微手术治疗的早期喉癌患者局部控制、喉保留及总生存率的预测因素。
经口激光显微手术(TLM)是早期喉癌的首选治疗方法。本研究旨在评估二氧化碳(CO2)激光显微手术治疗早期喉癌患者的疗效及有效性,并确定疗效的预测因素。
一项回顾性研究纳入了2009年至2016年间在海法卡梅尔医疗中心耳鼻咽喉头颈外科接受激光显微手术治疗的所有患者。我们根据局部控制、切缘状态、喉保留及总生存率评估疗效。I-V型声带切除术由欧洲喉科学会(ELS)分类。
74例早期喉癌患者接受了激光显微手术,平均年龄68.2±10.4岁,男性:女性为65:9,平均随访58±28个月。73%的患者为吸烟者。原发肿瘤位于声门的有68例(92%),声门上(5例-7%),声门下(1例-1%)。肿瘤分期如下:Tis:18例(24%),T1a:35例(47%),T1b:10例(14%),T2:11例(15%)。72例(97%)患者从患侧取材,64%(46例)切缘阴性,26例(36%)切缘阳性。切缘阳性的患者接受了进一步的激光手术(19%)或放疗(14%)。2例切缘阳性患者未接受治疗,平均随访26个月时均出现复发疾病,均接受了全喉切除术。按分期分层的5年局部控制率(LCR)如下:Tis-81.5%,T1a-88%,T1b-100%,T2-58%(无显著性差异)。总体5年局部控制率(LCR)为83%,切缘阳性或阴性患者之间无显著差异。总体5年生存率为87%,器官保留率为93%。
激光显微手术为早期喉癌提供了极佳的无病生存率/总生存率,在器官保留方面具有重要作用。切缘阳性患者与切缘阴性患者相比,在局部复发率(LRC)和总生存率方面未发现显著差异,这很可能是由于切缘阳性患者立即接受了进一步干预。